We’re excited to announce the approval and launch of a new feasibility trial to extend BCI control using the N1 Implant to an investigational assistive robotic arm. This is an important first step towards restoring not only digital freedom, but also physical freedom. More info to come, but the CONVOY Study will enable cross-enrolling participants from the ongoing PRIME Study. To read more about the PRIME study: https://lnkd.in/d7Zkd6Jt
Neuralink
Biotechnology Research
Fremont, California 352,307 followers
Neuralink is developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.
About us
Neuralink is a team of exceptionally talented people. We are creating the future of brain-machine interfaces: building devices now that will help people with paralysis and inventing new technologies that will expand our abilities, our community, and our world. Our goal is to build a system with at least two orders of magnitude more communication channels (electrodes) than current clinically-approved devices. This system needs to be safe, it must have fully wireless communication through the skin, and it has to be ready for patients to take home and use on their own. Our device, called the Link, will be able to record from 1024 electrodes and is designed to meet these criteria.
- Website
-
https://neuralink.com/careers
External link for Neuralink
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Fremont, California
- Type
- Privately Held
- Founded
- 2016
Locations
-
Primary
Fremont, California, US
-
Austin, TX, US
Employees at Neuralink
Updates
-
🇨🇦 We’re happy to announce that Health Canada has approved the launch of our first clinical trial in Canada! Recruitment is now open. If you have quadriplegia due to ALS or SCI, you may qualify. Visit our Patient Registry to learn more and apply. https://lnkd.in/e6T4FRxe
Patient Registry | Neuralink
neuralink.com
-
Early progress with our second participant https://lnkd.in/dR4Y4ReP
PRIME Study Progress Update — Second Participant
neuralink.com
-
🇬🇧 Neuralink’s Patient Registry is now open in the UK! Join us in shaping the future of brain-computer interfaces by learning more and applying today https://lnkd.in/eiyJ3QUX
Patient Registry UK | Neuralink
neuralink.com
-
Redefining the boundaries of human capability requires pioneers. If you have quadriplegia and want to explore new ways of controlling your computer, we invite you to participate in our clinical trial. https://lnkd.in/emjcUvvR
Shape the Future of Assistive Technology with Neuralink
https://www.youtube.com/
-
We use a game called Webgrid to test cursor control. Our first clinical trial participant achieved 8 BPS using his brain-computer interface. How well can you do? https://lnkd.in/eDtTfkbV
Play Webgrid | Neuralink
neuralink.com
-
We’ve just passed 100 days since the first participant in our clinical trial received his Neuralink implant. Read our latest progress update here: https://lnkd.in/d6CMsY8Z
PRIME Study Progress Update — User Experience
neuralink.com